The latest research study released by Market IntelliX evaluates market size and forecasts of Insulin Dosing Device in global, including the following market information:

Global Insulin Dosing Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Insulin Dosing Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Insulin Dosing Device companies in 2021 (%)

The global Insulin Dosing Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulin Dosing Device include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Copernicus, Dance Biopharm and Debiotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Insulin Dosing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Insulin Dosing Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, by Type, 2021 (%)

Insulin Pens

Insulin Pumps

Insulin Syringes

Others

Global Insulin Dosing Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Home Care

Others

Global Insulin Dosing Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Insulin Dosing Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Insulin Dosing Device revenues share in global market, 2021 (%)

Key companies Insulin Dosing Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Insulin Dosing Device sales share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Novo Nordisk

Sanofi

BD

Eli Lilly

Medtronic

Beta Bionics

Copernicus

Dance Biopharm

Debiotech

Insulet

MannKind

Owen Mumford

Roche

SOOIL

Tandem Diabetes Care

Valeritas

West Pharma

Ypsomed

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Insulin Dosing Device Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Insulin Dosing Device Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Insulin Dosing Device Overall Market Size

2.1 Global Insulin Dosing Device Market Size: 2021 VS 2028

2.2 Global Insulin Dosing Device Revenue, Prospects & Forecasts: 2017-2028

2.3 Global Insulin Dosing Device Sales: 2017-2028

3 Company Landscape

3.1 Top Insulin Dosing Device Players in Global Market

3.2 Top Global Insulin Dosing Device Companies Ranked by Revenue

3.3 Global Insulin Dosing Device Revenue by Companies

3.4 Global Insulin Dosing Device Sales by Companies

3.5 Global Insulin Dosing Device Price by Manufacturer (2017-2022)

3.6 Top 3 and Top 5 Insulin Dosing Device Companies in Global Market, by Revenue in 2021

3.7 Global Manufacturers Insulin Dosing Device Product Type

3.8 Tier 1, Tier 2 and Tier 3 Insulin Dosing Device Players in Global Market

3.8.1 List of Global Tier 1 Insulin Dosing Device Companies

3.8.2 List of Global Tier 2 and Tier 3 Insulin Dosing Device Companies

4 Sights by Product

4.1 Overview

4.1.1 By Type - Global Insulin Dosing Device Market Size Markets, 2021 & 2028

4.1.2 Insulin Pens

4.1.3 Insulin Pumps

4.1.4 Insulin Syringes

4.1.5 Others

4.2 By Type - Global Insulin Dosing Device Revenue & Forecasts

4.2.1 By Type - Global Insulin Dosing Device Revenue, 2017-2022

4.2.2 By Type - Global Insulin Dosing Device Revenue, 2023-2028

4.2.3 By Type - Global Insulin Dosing Device Revenue Market Share, 2017-2028

4.3 By Type - Global Insulin Dosing Device Sales & Forecasts

4.3.1 By Type - Global Insulin Dosing Device Sales, 2017-2022

4.3.2 By Type - Global Insulin Dosing Device Sales, 2023-2028

4.3.3 By Type - Global Insulin Dosing Device Sales Market Share, 2017-2028

4.4 By Type - Global Insulin Dosing Device Price (Manufacturers Selling Prices), 2017-2028

5 Sights By Application

5.1 Overview

5.1.1 By Application - Global Insulin Dosing Device Market Size, 2021 & 2028

5.1.2 Hospital

5.1.3 Clinic

5.1.4 Home Care

5.1.5 Others

5.2 By Application - Global Insulin Dosing Device Revenue & Forecasts

5.2.1 By Application - Global Insulin Dosing Device Revenue, 2017-2022

5.2.2 By Application - Global Insulin Dosing Device Revenue, 2023-2028

5.2.3 By Application - Global Insulin Dosing Device Revenue Market Share, 2017-2028

5.3 By Application - Global Insulin Dosing Device Sales & Forecasts

5.3.1 By Application - Global Insulin Dosing Device Sales, 2017-2022

5.3.2 By Application - Global Insulin Dosing Device Sales, 2023-2028

5.3.3 By Application - Global Insulin Dosing Device Sales Market Share, 2017-2028

5.4 By Application - Global Insulin Dosing Device Price (Manufacturers Selling Prices), 2017-2028

6 Sights by Region

6.1 By Region - Global Insulin Dosing Device Market Size, 2021 & 2028

6.2 By Region - Global Insulin Dosing Device Revenue & Forecasts

6.2.1 By Region - Global Insulin Dosing Device Revenue, 2017-2022

6.2.2 By Region - Global Insulin Dosing Device Revenue, 2023-2028

6.2.3 By Region - Global Insulin Dosing Device Revenue Market Share, 2017-2028

6.3 By Region - Global Insulin Dosing Device Sales & Forecasts

6.3.1 By Region - Global Insulin Dosing Device Sales, 2017-2022

6.3.2 By Region - Global Insulin Dosing Device Sales, 2023-2028

6.3.3 By Region - Global Insulin Dosing Device Sales Market Share, 2017-2028

6.4 North America

6.4.1 By Country - North America Insulin Dosing Device Revenue, 2017-2028

6.4.2 By Country - North America Insulin Dosing Device Sales, 2017-2028

6.4.3 US Insulin Dosing Device Market Size, 2017-2028

6.4.4 Canada Insulin Dosing Device Market Size, 2017-2028

6.4.5 Mexico Insulin Dosing Device Market Size, 2017-2028

6.5 Europe

6.5.1 By Country - Europe Insulin Dosing Device Revenue, 2017-2028

6.5.2 By Country - Europe Insulin Dosing Device Sales, 2017-2028

6.5.3 Germany Insulin Dosing Device Market Size, 2017-2028

6.5.4 France Insulin Dosing Device Market Size, 2017-2028

6.5.5 U.K. Insulin Dosing Device Market Size, 2017-2028

6.5.6 Italy Insulin Dosing Device Market Size, 2017-2028

6.5.7 Russia Insulin Dosing Device Market Size, 2017-2028

6.5.8 Nordic Countries Insulin Dosing Device Market Size, 2017-2028

6.5.9 Benelux Insulin Dosing Device Market Size, 2017-2028

6.6 Asia

6.6.1 By Region - Asia Insulin Dosing Device Revenue, 2017-2028

6.6.2 By Region - Asia Insulin Dosing Device Sales, 2017-2028

6.6.3 China Insulin Dosing Device Market Size, 2017-2028

6.6.4 Japan Insulin Dosing Device Market Size, 2017-2028

6.6.5 South Korea Insulin Dosing Device Market Size, 2017-2028

6.6.6 Southeast Asia Insulin Dosing Device Market Size, 2017-2028

6.6.7 India Insulin Dosing Device Market Size, 2017-2028

6.7 South America

6.7.1 By Country - South America Insulin Dosing Device Revenue, 2017-2028

6.7.2 By Country - South America Insulin Dosing Device Sales, 2017-2028

6.7.3 Brazil Insulin Dosing Device Market Size, 2017-2028

6.7.4 Argentina Insulin Dosing Device Market Size, 2017-2028

6.8 Middle East & Africa

6.8.1 By Country - Middle East & Africa Insulin Dosing Device Revenue, 2017-2028

6.8.2 By Country - Middle East & Africa Insulin Dosing Device Sales, 2017-2028

6.8.3 Turkey Insulin Dosing Device Market Size, 2017-2028

6.8.4 Israel Insulin Dosing Device Market Size, 2017-2028

6.8.5 Saudi Arabia Insulin Dosing Device Market Size, 2017-2028

6.8.6 UAE Insulin Dosing Device Market Size, 2017-2028

7 Manufacturers & Brands Profiles

7.1 Novo Nordisk

7.1.1 Novo Nordisk Corporate Summary

7.1.2 Novo Nordisk Business Overview

7.1.3 Novo Nordisk Insulin Dosing Device Major Product Offerings

7.1.4 Novo Nordisk Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.1.5 Novo Nordisk Key News

7.2 Sanofi

7.2.1 Sanofi Corporate Summary

7.2.2 Sanofi Business Overview

7.2.3 Sanofi Insulin Dosing Device Major Product Offerings

7.2.4 Sanofi Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.2.5 Sanofi Key News

7.3 BD

7.3.1 BD Corporate Summary

7.3.2 BD Business Overview

7.3.3 BD Insulin Dosing Device Major Product Offerings

7.3.4 BD Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.3.5 BD Key News

7.4 Eli Lilly

7.4.1 Eli Lilly Corporate Summary

7.4.2 Eli Lilly Business Overview

7.4.3 Eli Lilly Insulin Dosing Device Major Product Offerings

7.4.4 Eli Lilly Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.4.5 Eli Lilly Key News

7.5 Medtronic

7.5.1 Medtronic Corporate Summary

7.5.2 Medtronic Business Overview

7.5.3 Medtronic Insulin Dosing Device Major Product Offerings

7.5.4 Medtronic Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.5.5 Medtronic Key News

7.6 Beta Bionics

7.6.1 Beta Bionics Corporate Summary

7.6.2 Beta Bionics Business Overview

7.6.3 Beta Bionics Insulin Dosing Device Major Product Offerings

7.6.4 Beta Bionics Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.6.5 Beta Bionics Key News

7.7 Copernicus

7.7.1 Copernicus Corporate Summary

7.7.2 Copernicus Business Overview

7.7.3 Copernicus Insulin Dosing Device Major Product Offerings

7.7.4 Copernicus Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.7.5 Copernicus Key News

7.8 Dance Biopharm

7.8.1 Dance Biopharm Corporate Summary

7.8.2 Dance Biopharm Business Overview

7.8.3 Dance Biopharm Insulin Dosing Device Major Product Offerings

7.8.4 Dance Biopharm Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.8.5 Dance Biopharm Key News

7.9 Debiotech

7.9.1 Debiotech Corporate Summary

7.9.2 Debiotech Business Overview

7.9.3 Debiotech Insulin Dosing Device Major Product Offerings

7.9.4 Debiotech Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.9.5 Debiotech Key News

7.10 Insulet

7.10.1 Insulet Corporate Summary

7.10.2 Insulet Business Overview

7.10.3 Insulet Insulin Dosing Device Major Product Offerings

7.10.4 Insulet Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.10.5 Insulet Key News

7.11 MannKind

7.11.1 MannKind Corporate Summary

7.11.2 MannKind Insulin Dosing Device Business Overview

7.11.3 MannKind Insulin Dosing Device Major Product Offerings

7.11.4 MannKind Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.11.5 MannKind Key News

7.12 Owen Mumford

7.12.1 Owen Mumford Corporate Summary

7.12.2 Owen Mumford Insulin Dosing Device Business Overview

7.12.3 Owen Mumford Insulin Dosing Device Major Product Offerings

7.12.4 Owen Mumford Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.12.5 Owen Mumford Key News

7.13 Roche

7.13.1 Roche Corporate Summary

7.13.2 Roche Insulin Dosing Device Business Overview

7.13.3 Roche Insulin Dosing Device Major Product Offerings

7.13.4 Roche Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.13.5 Roche Key News

7.14 SOOIL

7.14.1 SOOIL Corporate Summary

7.14.2 SOOIL Business Overview

7.14.3 SOOIL Insulin Dosing Device Major Product Offerings

7.14.4 SOOIL Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.14.5 SOOIL Key News

7.15 Tandem Diabetes Care

7.15.1 Tandem Diabetes Care Corporate Summary

7.15.2 Tandem Diabetes Care Business Overview

7.15.3 Tandem Diabetes Care Insulin Dosing Device Major Product Offerings

7.15.4 Tandem Diabetes Care Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.15.5 Tandem Diabetes Care Key News

7.16 Valeritas

7.16.1 Valeritas Corporate Summary

7.16.2 Valeritas Business Overview

7.16.3 Valeritas Insulin Dosing Device Major Product Offerings

7.16.4 Valeritas Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.16.5 Valeritas Key News

7.17 West Pharma

7.17.1 West Pharma Corporate Summary

7.17.2 West Pharma Business Overview

7.17.3 West Pharma Insulin Dosing Device Major Product Offerings

7.17.4 West Pharma Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.17.5 West Pharma Key News

7.18 Ypsomed

7.18.1 Ypsomed Corporate Summary

7.18.2 Ypsomed Business Overview

7.18.3 Ypsomed Insulin Dosing Device Major Product Offerings

7.18.4 Ypsomed Insulin Dosing Device Sales and Revenue in Global (2017-2022)

7.18.5 Ypsomed Key News

8 Global Insulin Dosing Device Production Capacity, Analysis

8.1 Global Insulin Dosing Device Production Capacity, 2017-2028

8.2 Insulin Dosing Device Production Capacity of Key Manufacturers in Global Market

8.3 Global Insulin Dosing Device Production by Region

9 Key Market Trends, Opportunity, Drivers and Restraints

9.1 Market Opportunities & Trends

9.2 Market Drivers

9.3 Market Restraints

10 Insulin Dosing Device Supply Chain Analysis

10.1 Insulin Dosing Device Industry Value Chain

10.2 Insulin Dosing Device Upstream Market

10.3 Insulin Dosing Device Downstream and Clients

10.4 Marketing Channels Analysis

10.4.1 Marketing Channels

10.4.2 Insulin Dosing Device Distributors and Sales Agents in Global

11 Conclusion

12 Appendix

12.1 Note

12.2 Examples of Clients

12.3 Disclaimer

List of Tables

Table 1. Key Players of Insulin Dosing Device in Global Market

Table 2. Top Insulin Dosing Device Players in Global Market, Ranking by Revenue (2021)

Table 3. Global Insulin Dosing Device Revenue by Companies, (US$, Mn), 2017-2022

Table 4. Global Insulin Dosing Device Revenue Share by Companies, 2017-2022

Table 5. Global Insulin Dosing Device Sales by Companies, (K Units), 2017-2022

Table 6. Global Insulin Dosing Device Sales Share by Companies, 2017-2022

Table 7. Key Manufacturers Insulin Dosing Device Price (2017-2022) & (US$/Unit)

Table 8. Global Manufacturers Insulin Dosing Device Product Type

Table 9. List of Global Tier 1 Insulin Dosing Device Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Insulin Dosing Device Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022

Table 13. By Type - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028

Table 14. By Type - Global Insulin Dosing Device Sales (K Units), 2017-2022

Table 15. By Type - Global Insulin Dosing Device Sales (K Units), 2023-2028

Table 16. By Application – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 & 2028

Table 17. By Application - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022

Table 18. By Application - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028

Table 19. By Application - Global Insulin Dosing Device Sales (K Units), 2017-2022

Table 20. By Application - Global Insulin Dosing Device Sales (K Units), 2023-2028

Table 21. By Region – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 VS 2028

Table 22. By Region - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022

Table 23. By Region - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028

Table 24. By Region - Global Insulin Dosing Device Sales (K Units), 2017-2022

Table 25. By Region - Global Insulin Dosing Device Sales (K Units), 2023-2028

Table 26. By Country - North America Insulin Dosing Device Revenue, (US$, Mn), 2017-2022

Table 27. By Country - North America Insulin Dosing Device Revenue, (US$, Mn), 2023-2028

Table 28. By Country - North America Insulin Dosing Device Sales, (K Units), 2017-2022

Table 29. By Country - North America Insulin Dosing Device Sales, (K Units), 2023-2028

Table 30. By Country - Europe Insulin Dosing Device Revenue, (US$, Mn), 2017-2022

Table 31. By Country - Europe Insulin Dosing Device Revenue, (US$, Mn), 2023-2028

Table 32. By Country - Europe Insulin Dosing Device Sales, (K Units), 2017-2022

Table 33. By Country - Europe Insulin Dosing Device Sales, (K Units), 2023-2028

Table 34. By Region - Asia Insulin Dosing Device Revenue, (US$, Mn), 2017-2022

Table 35. By Region - Asia Insulin Dosing Device Revenue, (US$, Mn), 2023-2028

Table 36. By Region - Asia Insulin Dosing Device Sales, (K Units), 2017-2022

Table 37. By Region - Asia Insulin Dosing Device Sales, (K Units), 2023-2028

Table 38. By Country - South America Insulin Dosing Device Revenue, (US$, Mn), 2017-2022

Table 39. By Country - South America Insulin Dosing Device Revenue, (US$, Mn), 2023-2028

Table 40. By Country - South America Insulin Dosing Device Sales, (K Units), 2017-2022

Table 41. By Country - South America Insulin Dosing Device Sales, (K Units), 2023-2028

Table 42. By Country - Middle East & Africa Insulin Dosing Device Revenue, (US$, Mn), 2017-2022

Table 43. By Country - Middle East & Africa Insulin Dosing Device Revenue, (US$, Mn), 2023-2028

Table 44. By Country - Middle East & Africa Insulin Dosing Device Sales, (K Units), 2017-2022

Table 45. By Country - Middle East & Africa Insulin Dosing Device Sales, (K Units), 2023-2028

Table 46. Novo Nordisk Corporate Summary

Table 47. Novo Nordisk Insulin Dosing Device Product Offerings

Table 48. Novo Nordisk Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 49. Sanofi Corporate Summary

Table 50. Sanofi Insulin Dosing Device Product Offerings

Table 51. Sanofi Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 52. BD Corporate Summary

Table 53. BD Insulin Dosing Device Product Offerings

Table 54. BD Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 55. Eli Lilly Corporate Summary

Table 56. Eli Lilly Insulin Dosing Device Product Offerings

Table 57. Eli Lilly Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 58. Medtronic Corporate Summary

Table 59. Medtronic Insulin Dosing Device Product Offerings

Table 60. Medtronic Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 61. Beta Bionics Corporate Summary

Table 62. Beta Bionics Insulin Dosing Device Product Offerings

Table 63. Beta Bionics Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 64. Copernicus Corporate Summary

Table 65. Copernicus Insulin Dosing Device Product Offerings

Table 66. Copernicus Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 67. Dance Biopharm Corporate Summary

Table 68. Dance Biopharm Insulin Dosing Device Product Offerings

Table 69. Dance Biopharm Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 70. Debiotech Corporate Summary

Table 71. Debiotech Insulin Dosing Device Product Offerings

Table 72. Debiotech Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 73. Insulet Corporate Summary

Table 74. Insulet Insulin Dosing Device Product Offerings

Table 75. Insulet Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 76. MannKind Corporate Summary

Table 77. MannKind Insulin Dosing Device Product Offerings

Table 78. MannKind Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 79. Owen Mumford Corporate Summary

Table 80. Owen Mumford Insulin Dosing Device Product Offerings

Table 81. Owen Mumford Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 82. Roche Corporate Summary

Table 83. Roche Insulin Dosing Device Product Offerings

Table 84. Roche Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 85. SOOIL Corporate Summary

Table 86. SOOIL Insulin Dosing Device Product Offerings

Table 87. SOOIL Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 88. Tandem Diabetes Care Corporate Summary

Table 89. Tandem Diabetes Care Insulin Dosing Device Product Offerings

Table 90. Tandem Diabetes Care Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 91. Valeritas Corporate Summary

Table 92. Valeritas Insulin Dosing Device Product Offerings

Table 93. Valeritas Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 94. West Pharma Corporate Summary

Table 95. West Pharma Insulin Dosing Device Product Offerings

Table 96. West Pharma Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 97. Ypsomed Corporate Summary

Table 98. Ypsomed Insulin Dosing Device Product Offerings

Table 99. Ypsomed Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 100. Insulin Dosing Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)

Table 101. Global Insulin Dosing Device Capacity Market Share of Key Manufacturers, 2020-2022

Table 102. Global Insulin Dosing Device Production by Region, 2017-2022 (K Units)

Table 103. Global Insulin Dosing Device Production by Region, 2023-2028 (K Units)

Table 104. Insulin Dosing Device Market Opportunities & Trends in Global Market

Table 105. Insulin Dosing Device Market Drivers in Global Market

Table 106. Insulin Dosing Device Market Restraints in Global Market

Table 107. Insulin Dosing Device Raw Materials

Table 108. Insulin Dosing Device Raw Materials Suppliers in Global Market

Table 109. Typical Insulin Dosing Device Downstream

Table 110. Insulin Dosing Device Downstream Clients in Global Market

Table 111. Insulin Dosing Device Distributors and Sales Agents in Global Market

List of Figures

Figure 1. Insulin Dosing Device Segment by Type

Figure 2. Insulin Dosing Device Segment by Application

Figure 3. Global Insulin Dosing Device Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Insulin Dosing Device Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Insulin Dosing Device Revenue, 2017-2028 (US$, Mn)

Figure 7. Insulin Dosing Device Sales in Global Market: 2017-2028 (K Units)

Figure 8. The Top 3 and 5 Players Market Share by Insulin Dosing Device Revenue in 2021

Figure 9. By Type - Global Insulin Dosing Device Sales Market Share, 2017-2028

Figure 10. By Type - Global Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 11. By Type - Global Insulin Dosing Device Price (US$/Unit), 2017-2028

Figure 12. By Application - Global Insulin Dosing Device Sales Market Share, 2017-2028

Figure 13. By Application - Global Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 14. By Application - Global Insulin Dosing Device Price (US$/Unit), 2017-2028

Figure 15. By Region - Global Insulin Dosing Device Sales Market Share, 2017-2028

Figure 16. By Region - Global Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 17. By Country - North America Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 18. By Country - North America Insulin Dosing Device Sales Market Share, 2017-2028

Figure 19. US Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 20. Canada Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 21. Mexico Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 22. By Country - Europe Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 23. By Country - Europe Insulin Dosing Device Sales Market Share, 2017-2028

Figure 24. Germany Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 25. France Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 26. U.K. Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 27. Italy Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 28. Russia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 29. Nordic Countries Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 30. Benelux Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 31. By Region - Asia Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 32. By Region - Asia Insulin Dosing Device Sales Market Share, 2017-2028

Figure 33. China Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 34. Japan Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 35. South Korea Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 36. Southeast Asia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 37. India Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 38. By Country - South America Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 39. By Country - South America Insulin Dosing Device Sales Market Share, 2017-2028

Figure 40. Brazil Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 41. Argentina Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 42. By Country - Middle East & Africa Insulin Dosing Device Revenue Market Share, 2017-2028

Figure 43. By Country - Middle East & Africa Insulin Dosing Device Sales Market Share, 2017-2028

Figure 44. Turkey Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 45. Israel Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 46. Saudi Arabia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 47. UAE Insulin Dosing Device Revenue, (US$, Mn), 2017-2028

Figure 48. Global Insulin Dosing Device Production Capacity (K Units), 2017-2028

Figure 49. The Percentage of Production Insulin Dosing Device by Region, 2021 VS 2028

Figure 50. Insulin Dosing Device Industry Value Chain

Figure 51. Marketing Channels

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)